About Bioeq AG
Bioeq AG is a Swiss biopharmaceutical joint venture backed by the leading biosimilar developers Polpharma Biologics Group and Formycon AG and is based in Zug. We license, develop and commercialise a biosimilar, which is a successor product of Lucentis® (ranibizumab), a successful branded biopharmaceutical. We are a young and dynamic company, supported by an international network of experts. Bioeq AG out-licenses its products to established international pharmaceutical companies who ensure local distribution in each territory.
- Employees
- 1 to 10
- Headquarters
- Zug
Leadership
The top of Bioeq AG's org chart, with how many people report into each leader.
Martin Huber
Managing Director
10 reports
Thiemo Schreiber
Vice President Commercial & Operations
4 reports
Peter Durrer
Head Qa, Bioeq AG
3 reports
Akos Mile
Finance Director
Jobs at Bioeq AG
No open positions right now. Explore more companies on TheJobsMap.